BCVS- Gangjian Qin

Gangjian Qin, MD, FAHA, is Professor of Medicine and Engineering, Director of the Molecular Cardiology Program, Vice Chair for Research of the Department of Biomedical Engineering at University of Alabama Birmingham. Dr. Qin’s research program is dedicated to defining the molecular mechanisms that underlie cardiovascular biology and contribute to the recovery from cardiovascular disease, and to translating the results from these basic science investigations to clinical applications. His lab discovered the roles of the E2F oncogenes in the ischemic angiogenesis and blood pressure regulation; identified a unique population of cardiac stem cells in the rodent heart; characterized the signaling mechanisms of SDF-1/CXCR4 axis in the maintenance of bone marrow stem cell niche; and most recently, revealed a pivotal role of oxidative metabolism in the EPC differentiation. Dr. Qin has published over 90 original research articles in major international journals. He serves on the editorial boards of a dozen biomedical journals including Circulation Research and on the grant review committees for the NIH, VA, AHA, CASIS, and a number of international funding agencies. His research is continuously supported by NIH, AHA, and the American Diabetes Association (ADA). Over the last 15 years, Dr. Qin’s lab has trained or is training over 25 research trainees including junior faculties, postdoc fellows, PhD students, and undergraduate students.

Medical Specialty:

Regenerative Medicine, Gene and Cell Therapy

Basic and Translational Science

Diabetes and Metabolism

Add: Tower A, 17/F, Huaxin Mansion, 33 Anding Road, Chaoyang District, Beijing, China 100029
Tel: +86-10-52882835
Email: secretariat@cardiounion.cn